ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 183 filers reported holding ALKERMES PLC in Q3 2020. The put-call ratio across all filers is 9.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,179,959 | -12.0% | 220,634 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $7,023,252 | +12.6% | 224,385 | +1.4% | 0.00% | 0.0% |
| Q1 2023 | $6,238,278 | +14.6% | 221,294 | +6.2% | 0.00% | 0.0% |
| Q4 2022 | $5,445,000 | -40.2% | 208,339 | -48.9% | 0.00% | -33.3% |
| Q3 2022 | $9,102,000 | -32.3% | 407,610 | -9.7% | 0.00% | -40.0% |
| Q2 2022 | $13,449,000 | +86.5% | 451,412 | +64.7% | 0.01% | +150.0% |
| Q1 2022 | $7,211,000 | +9.8% | 274,062 | -2.9% | 0.00% | 0.0% |
| Q4 2021 | $6,568,000 | +101.7% | 282,339 | +167.3% | 0.00% | +100.0% |
| Q3 2021 | $3,256,000 | +30.3% | 105,607 | +3.6% | 0.00% | 0.0% |
| Q2 2021 | $2,498,000 | +33.2% | 101,914 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $1,875,000 | -15.7% | 100,350 | -9.9% | 0.00% | 0.0% |
| Q4 2020 | $2,223,000 | +16.6% | 111,434 | -3.1% | 0.00% | 0.0% |
| Q3 2020 | $1,907,000 | -13.0% | 115,050 | +1.9% | 0.00% | 0.0% |
| Q2 2020 | $2,191,000 | +4.4% | 112,865 | -22.5% | 0.00% | 0.0% |
| Q1 2020 | $2,098,000 | +12.3% | 145,565 | +59.0% | 0.00% | 0.0% |
| Q4 2019 | $1,869,000 | +632.9% | 91,578 | +713.1% | 0.00% | – |
| Q2 2019 | $255,000 | -98.8% | 11,263 | -98.0% | 0.00% | -100.0% |
| Q1 2019 | $20,824,000 | -8.7% | 570,670 | -26.2% | 0.01% | -9.1% |
| Q4 2018 | $22,813,000 | +895.8% | 773,076 | +1334.9% | 0.01% | +1000.0% |
| Q3 2018 | $2,291,000 | -89.7% | 53,877 | -90.0% | 0.00% | -90.0% |
| Q2 2018 | $22,191,000 | -62.3% | 539,178 | -46.8% | 0.01% | -63.0% |
| Q1 2018 | $58,795,000 | +138.7% | 1,014,374 | +125.3% | 0.03% | +145.5% |
| Q4 2017 | $24,635,000 | -10.8% | 450,271 | -17.2% | 0.01% | -15.4% |
| Q3 2017 | $27,631,000 | -4.5% | 543,486 | +8.8% | 0.01% | -7.1% |
| Q2 2017 | $28,940,000 | +9.1% | 499,313 | +10.1% | 0.01% | 0.0% |
| Q1 2017 | $26,525,000 | -70.6% | 453,490 | -72.1% | 0.01% | -71.4% |
| Q4 2016 | $90,255,000 | +14.9% | 1,623,915 | -2.8% | 0.05% | +11.4% |
| Q3 2016 | $78,559,000 | +8.1% | 1,670,376 | -0.7% | 0.04% | +2.3% |
| Q2 2016 | $72,690,000 | -2.0% | 1,682,037 | -22.5% | 0.04% | -2.3% |
| Q1 2016 | $74,197,000 | -73.2% | 2,170,140 | -37.8% | 0.04% | -73.0% |
| Q4 2015 | $277,113,000 | +49.6% | 3,491,167 | +10.6% | 0.16% | +41.7% |
| Q3 2015 | $185,271,000 | +6.1% | 3,157,943 | +16.4% | 0.12% | +16.2% |
| Q2 2015 | $174,587,000 | +5.8% | 2,713,529 | +0.3% | 0.10% | +4.2% |
| Q1 2015 | $165,029,000 | +145.2% | 2,706,758 | +135.5% | 0.10% | +143.6% |
| Q4 2014 | $67,294,000 | +31.1% | 1,149,130 | -4.0% | 0.04% | +25.8% |
| Q3 2014 | $51,331,000 | +21.3% | 1,197,354 | +42.4% | 0.03% | +24.0% |
| Q2 2014 | $42,309,000 | +986.0% | 840,637 | +851.6% | 0.02% | +1150.0% |
| Q1 2014 | $3,896,000 | +9402.4% | 88,336 | +8733.6% | 0.00% | – |
| Q4 2013 | $41,000 | -99.8% | 1,000 | -99.8% | 0.00% | -100.0% |
| Q3 2013 | $18,112,000 | -37.9% | 538,732 | -47.1% | 0.01% | -40.0% |
| Q2 2013 | $29,182,000 | – | 1,017,516 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |